Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Saba, NF; Klinghammer, K; Castelluci, E; Colevas, AD; Rutkowski, T; Thurner, D; Müller-Richter, U; Maio, M; Grewal, JS; Ottensmeier, CHH; Dias, J; Yang, H; Das, R; Furlanetto, J; Herzfeldt, AK; Kühnle, MC; Ulges, A; Alles, J; Türeci, Ö; Sahin, U.
Exploratory efficacy and translational results from the safety run in of AHEAD-MERIT, a phase II trial of first line pembrolizumab plus the fixed-antigen cancer vaccine BNT113 in advanced HPV16+HNSCC
ANN ONCOL. 2024; 35: S627-S627. Doi: 10.1016/j.annonc.2024.08.938
Web of Science FullText FullText_MUG

Authors Med Uni Graz:: Thurnher Dietmar
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):